Neoadjuvant Toripalimab and Axitinib Shows Activity in Mucosal Melanoma
Neoadjuvant treatment with toripalimab and axitinib has demonstrated efficacy in a phase 2 trial of patients with resectable mucosal melanoma.
Fewer Cycles of Neoadjuvant Chemotherapy Linked to Better Survival in Ovarian Cancer
Receiving fewer cycles of neoadjuvant chemotherapy and undergoing surgery earlier is associated with better survival outcomes in patients with advanced epithelial ovarian cancer, a meta-analysis suggests.
Study Identifies Familial Germline EGFR T790M Variant in Lung Cancer
4.1-Mb haplotype identified, which was shared by 89 percent of 46 carriers of a germline EGFR T790M mutation.
Approximately 10% of Returned Fecal Immunochemical Tests Unsatisfactory
Researchers conducted a large-scale study to determine the prevalence and characteristics of unsatisfactory FIT.
ASCO Issues Guidance for Managing “Unprecedented” Cancer Drug Shortages
ASCO has released guidelines on how to treat patients amid current cancer drug shortages.
Never-Smokers and Ever-Smokers Have Similar Risk of Second Primary Lung Cancer
Lung cancer survivors who have never smoked have a similar risk of developing a second primary lung cancer as survivors with a history of smoking, data suggest.
Overall Survival Benefit Up for Pyrotinib + Capecitabine in HER2-Positive Breast Cancer
Overall survival benefit demonstrated among patients with metastatic breast cancer who had received trastuzumab and taxanes.
NCCN Guidelines Favor Cancer Drugs Granted Regular Approval
Cancer drugs that are granted accelerated approval are less likely than drugs with regular approval to be given high-level evidence ratings and preferred status in NCCN guidelines, a new study suggests.
Redispensing Quality-Approved Oral Anticancer Drugs Decreases Costs
Researchers explored the feasibility of redispensing unused oral anticancer drugs as a means of reducing waste and decreasing costs.
Wildfire Smoke May Increase Risk of New Cancer, Poor Outcomes of Existing Cancer
Exposure to wildfire smoke may be associated with an increased risk of developing cancer and poor outcomes among patients with existing cancer.
- Loading...
